Literature DB >> 26436483

Apelin/APJ signaling in hypoxia-related diseases.

Lu He1, Jin Xu1, Linxi Chen2, Lanfang Li3.   

Abstract

The regulatory peptide apelin is the endogenous ligand for the orphan G protein-coupled receptor APJ. Apelin and APJ exist in a variety of tissues, with special status in the heart, lung and tumors. Consequently, the apelin/APJ system exerts a broad range of activities that affect multiple organ systems. Accumulating evidence indicates that the expressions of apelin and APJ are significantly augmented by hypoxia through the hypoxia-inducible factor-1 alpha (HIF-1α) signaling pathway. Increased apelin promotes cellular proliferation, migration and survival, therefore regulating angiogenesis. In addition, the pre-administration of exogenous apelin is involved in the occurrence and development of hypoxia-induced pathological diseases. The purpose of this article is to review the properties of the apelin/APJ system, which is affected by hypoxic conditions, and the regulation of apelin/APJ signaling in hypoxia-associated disorders. Thus, the apelin/APJ system may be a potential therapeutic target in hypoxia-related diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apelin/APJ; Hypoxia-related diseases; Hypoxia/hypoxia-inducible factor-1 alpha

Mesh:

Substances:

Year:  2015        PMID: 26436483     DOI: 10.1016/j.cca.2015.09.029

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

Review 1.  Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.

Authors:  Mei-qing Liu; Zhe Chen; Lin-xi Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

2.  Apelin/APJ system: a novel promising therapy target for thrombotic diseases.

Authors:  Lanfang Li; Jin Xu; Linxi Chen; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-15       Impact factor: 3.848

3.  Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.

Authors:  Meiyan Feng; Guodong Yao; Hongwei Yu; Yu Qing; Kuan Wang
Journal:  BMC Cancer       Date:  2016-10-12       Impact factor: 4.430

Review 4.  Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential.

Authors:  Yili Wu; Xin Wang; Xuan Zhou; Baohua Cheng; Gongying Li; Bo Bai
Journal:  Front Mol Neurosci       Date:  2017-01-23       Impact factor: 5.639

5.  Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases.

Authors:  Wei Hu; Wan Jiang; Li Ye; Yanghua Tian; Bing Shen; Kai Wang
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 6.  The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.

Authors:  Marta B Wysocka; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

7.  Identification and Validation of Potential Biomarkers and Their Functions in Acute Kidney Injury.

Authors:  Jianwen Chen; Yalei Chen; Alberto Olivero; Xiangmei Chen
Journal:  Front Genet       Date:  2020-05-12       Impact factor: 4.599

8.  Can apelin play a role in the etiology of tinnitus?

Authors:  Nuray Ensari; Özer Erdem Gür; Nilgün Gür; Ömer Tarık Selçuk; Levent Renda; Mustafa Deniz Yılmaz; Mehmet Türker Öztürk; Yeşim Çekin
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

9.  A network map of apelin-mediated signaling.

Authors:  Shobha Dagamajalu; D A B Rex; Pushparani Devi Philem; Jan K Rainey; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2021-04-02       Impact factor: 5.782

10.  Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis.

Authors:  Jingying Hou; Lei Wang; Huibao Long; Hao Wu; Quanhua Wu; Tingting Zhong; Xuxiang Chen; Changqing Zhou; Tianzhu Guo; Tong Wang
Journal:  Stem Cell Res Ther       Date:  2017-09-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.